0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Comparison of pneumonia features in children caused by SARS‐CoV‐2 and other viral respiratory pathogens

      research-article
      , MD, PhD 1 , , , BS, MStat 2 , , MD, PhD 3 , , MD, PhD 3 , 4 , , MD, PhD 3 , , MD 3 , , MD 3 , , MD, PhD 3 , , PhD 5 , , MD 5 , , MD 5 , , MD 6 , , MD 6 , , MD 7 , , MD 7 , 8 , , PhD 2 , 9 , , MD 9 , , MD 10 , , MD 11 , , MD 12 , , MD 13 , , MD, PhD 1 , , MD, PhD 14 , , BPharm 15 , 16 , , BPharm 15 , 16 , , MD 1 , , MSc 2 , , MD 2 , , MD, PhD 1 , 2
      Pediatric Pulmonology
      John Wiley and Sons Inc.
      chest X‐ray, clinical features, pneumonia in children, SARS‐CoV‐2, severity

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Pneumonia is a frequent manifestation of coronavirus disease 2019 (COVID‐19) in hospitalized children.

          Methods

          The study involved 80 hospitals in the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spanish Pediatric National Cohort. Participants were children <18 years, hospitalized with SARS‐CoV‐2 community‐acquired pneumonia (CAP). We compared the clinical and radiological characteristics of SARS‐CoV‐2‐associated CAP with CAP due to other viral etiologies from ValsDance (retrospective) cohort.

          Results

          In total, 151 children with SARS‐CoV‐2‐associated CAP and 138 with other viral CAP were included. Main clinical features of SARS‐CoV‐2‐associated CAP were cough, fever, or dyspnea. Lymphopenia was found in 43% patients and 15% required admission to the pediatric intensive care unit (PICU). Chest X‐ray revealed condensation (42%) and other infiltrates (58%). Compared with CAP from other viral pathogens, COVID‐19 patients were older, with lower C‐reactive protein (CRP) levels, less wheezing, and greater need of mechanical ventilation (MV). There were no differences in the use of continuous positive airway pressure (CPAP) or HVF, or PICU admission between groups.

          Conclusion

          SARS‐CoV‐2‐associated CAP in children presents differently to other virus‐associated CAP: children are older and rarely have wheezing or high CRP levels; they need less oxygen but more CPAP or MV. However, several features overlap and differentiating the etiology may be difficult. The overall prognosis is good.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical Characteristics of Coronavirus Disease 2019 in China

          Abstract Background Since December 2019, when coronavirus disease 2019 (Covid-19) emerged in Wuhan city and rapidly spread throughout China, data have been needed on the clinical characteristics of the affected patients. Methods We extracted data regarding 1099 patients with laboratory-confirmed Covid-19 from 552 hospitals in 30 provinces, autonomous regions, and municipalities in mainland China through January 29, 2020. The primary composite end point was admission to an intensive care unit (ICU), the use of mechanical ventilation, or death. Results The median age of the patients was 47 years; 41.9% of the patients were female. The primary composite end point occurred in 67 patients (6.1%), including 5.0% who were admitted to the ICU, 2.3% who underwent invasive mechanical ventilation, and 1.4% who died. Only 1.9% of the patients had a history of direct contact with wildlife. Among nonresidents of Wuhan, 72.3% had contact with residents of Wuhan, including 31.3% who had visited the city. The most common symptoms were fever (43.8% on admission and 88.7% during hospitalization) and cough (67.8%). Diarrhea was uncommon (3.8%). The median incubation period was 4 days (interquartile range, 2 to 7). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (CT) (56.4%). No radiographic or CT abnormality was found in 157 of 877 patients (17.9%) with nonsevere disease and in 5 of 173 patients (2.9%) with severe disease. Lymphocytopenia was present in 83.2% of the patients on admission. Conclusions During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients often presented without fever, and many did not have abnormal radiologic findings. (Funded by the National Health Commission of China and others.)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults

            Abstract Aim The coronavirus disease 2019 (COVID‐19) pandemic has affected hundreds of thousands of people. Data on symptoms and prognosis in children are rare. Methods A systematic literature review was carried out to identify papers on COVID‐19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), using the MEDLINE and Embase databases between January 1 and March 18, 2020. Results The search identified 45 relevant scientific papers and letters. The review showed that children have so far accounted for 1%‐5% of diagnosed COVID‐19 cases, they often have milder disease than adults and deaths have been extremely rare. Diagnostic findings have been similar to adults, with fever and respiratory symptoms being prevalent, but fewer children seem to have developed severe pneumonia. Elevated inflammatory markers were less common in children, and lymphocytopenia seemed rare. Newborn infants have developed symptomatic COVID‐19, but evidence of vertical intrauterine transmission was scarce. Suggested treatment included providing oxygen, inhalations, nutritional support and maintaining fluids and electrolyte balances. Conclusions The coronavirus disease 2019 has occurred in children, but they seemed to have a milder disease course and better prognosis than adults. Deaths were extremely rare.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Acute respiratory failure in COVID-19: is it “typical” ARDS?

              In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) was identified in Wuhan, China. The World Health Organization (WHO) declared this outbreak a significant threat to international health. COVID-19 is highly infectious and can lead to fatal comorbidities especially acute respiratory distress syndrome (ARDS). Thus, fully understanding the characteristics of COVID-19-related ARDS is conducive to early identification and precise treatment. We aimed to describe the characteristics of COVID-19-related ARDS and to elucidate the differences from ARDS caused by other factors. COVID-19 mainly affected the respiratory system with minor damage to other organs. Injury to the alveolar epithelial cells was the main cause of COVID-19-related ARDS, and endothelial cells were less damaged with therefore less exudation. The clinical manifestations were relatively mild in some COVID-19 patients, which was inconsistent with the severity of laboratory and imaging findings. The onset time of COVID-19-related ARDS was 8–12 days, which was inconsistent with ARDS Berlin criteria, which defined a 1-week onset limit. Some of these patients might have a relatively normal lung compliance. The severity was redefined into three stages according to its specificity: mild, mild-moderate, and moderate-severe. HFNO can be safe in COVID-19-related ARDS patients, even in some moderate-severe patients. The more likely cause of death is severe respiratory failure. Thus, the timing of invasive mechanical ventilation is very important. The effects of corticosteroids in COVID-19-related ARDS patients were uncertain. We hope to help improve the prognosis of severe cases and reduce the mortality.
                Bookmark

                Author and article information

                Contributors
                rutdelvalle@hotmail.com , ruth.valle@salud.madrid.org
                Journal
                Pediatr Pulmonol
                Pediatr Pulmonol
                10.1002/(ISSN)1099-0496
                PPUL
                Pediatric Pulmonology
                John Wiley and Sons Inc. (Hoboken )
                8755-6863
                1099-0496
                08 July 2022
                08 July 2022
                : 10.1002/ppul.26042
                Affiliations
                [ 1 ] Pediatrics Department, Pediatrics Research Group, Hospital Universitario Infanta Sofía Universidad Europea de Madrid Madrid Spain
                [ 2 ] Pediatric Research and Clinical Trials Unit (UPIC), Pediatrics Department, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Fundación de Investigación Biomédica Hospital 12 de Octubre RITIP (Translational Research Network in Paediatric Infectious Diseases) Madrid Spain
                [ 3 ] Pediatrics, Infectious and Tropical Diseases Department, Hospital Universitario La Paz, Instituto Investigación Hospital La Paz (IDIPaz) RITIP (Translational Research Network in Paediatric Infectious Diseases) Madrid Spain
                [ 4 ] Research Center, Centro de Investigación en Red en Enfermedades Infecciosas (CIBERINFEC) Instituto de Salud Carlos III, Madrid, Spain Madrid Spain
                [ 5 ] Pediatrics Department Hospital Universitario Niño Jesús Madrid Spain
                [ 6 ] Infectious Diseases and Pediatric Immunology Unit, Department of Pediatrics Hospital Universitario Vall d'Hebron Barcelona Spain
                [ 7 ] Pediatric Infectious Diseases Unit, Department of Pediatrics Hospital Universitario Gregorio Marañón Madrid Spain
                [ 8 ] Research Center Gregorio Marañón Research Institute (IiSGM) Madrid Spain
                [ 9 ] Pediatric Infectious Diseases Unit, Department of Pediatrics Hospital Universitario 12 de Octubre Madrid Spain
                [ 10 ] Pediatrics Department Complejo Hospitalario de Navarra Pamplona Spain
                [ 11 ] Pediatrics Department Hospital Universitario Clínico San Carlos Madrid Spain
                [ 12 ] Pediatric Intensive Care Unit Department Hospital La Moraleja Madrid Spain
                [ 13 ] Pediatric Infectious Diseases Unit, Pediatrics Department Hospital Universitari i Politècnic La Fe Valencia Spain
                [ 14 ] Pediatrics Department, Hospital Universitario Ramón y Cajal Universidad de Alcalá Madrid Madrid Spain
                [ 15 ] Microbiology Department, Hospital Universitario Ramón y Cajal Instituto Ramón y Cajal para la Investigación Sanitaria (IRYCIS) Madrid Spain
                [ 16 ] Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP) Madrid Spain
                Author notes
                [*] [* ] Correspondence Rut del Valle, Servicio de Pediatría, Hospital Universitario Infanta Sofía, Paseo de Europa, 34. 28703, San Sebastián de los Reyes, Madrid, Spain.

                Email: rutdelvalle@ 123456hotmail.com and ruth.valle@ 123456salud.madrid.org

                Author information
                http://orcid.org/0000-0001-8740-7601
                http://orcid.org/0000-0002-6503-3423
                https://orcid.org/0000-0001-9891-0456
                Article
                PPUL26042
                10.1002/ppul.26042
                9349806
                35754093
                eb2b702e-8e56-4185-ba3e-a825f1dfac34
                © 2022 Wiley Periodicals LLC.

                This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

                History
                : 01 May 2022
                : 30 November 2021
                : 23 June 2022
                Page count
                Figures: 2, Tables: 2, Pages: 9, Words: 5565
                Funding
                Funded by: Instituto de Salud Carlos III , doi 10.13039/501100004587;
                Award ID: PI20/00095
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                corrected-proof
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.7 mode:remove_FC converted:04.08.2022

                Pediatrics
                chest x‐ray,clinical features,pneumonia in children,sars‐cov‐2,severity
                Pediatrics
                chest x‐ray, clinical features, pneumonia in children, sars‐cov‐2, severity

                Comments

                Comment on this article